Immigration Raids Seen Driving Patients Towards Telehealth
“People are not picking up their medicine; they’re not seeing the doctor,” St. John’s Community Health clinics’ CEO says
Read More
Why Employers Predict a 10% Increase in Healthcare Costs for 2026
Employers are projecting a median 10% increase in healthcare costs for 2026, driven largely by high claims and specialty drug expenses, according to a recent survey. The post Why Employers Predict a 10% Increase in Healthcare Costs for 2026 appeared first on MedCity News.
U.S. Foreign Aid Freeze & Dissolution of USAID: Timeline of Events
This timeline provides a detailed overview of actions, including counter-actions, related to the administration’s efforts to freeze all U.S. foreign aid and dissolve the U.S. Agency for International Development (USAID).
Overview of President Trump’s Executive Actions on Global Health
This guide provides an overview of executive orders and other executive actions made by the Trump Administration since January 21, 2025 that directly address or affect U.S. global health efforts. This resource identifies each executive action, describes its purpose and actions taken, and outlines the implications and what happens next for each. The resource will…
Reduced ACA Subsidies May Make It Harder for Young Adults To Afford Coverage
As they move into adulthood, many young Americans face a unique and daunting challenge: finding their own health insurance by the time they turn 26. The lucky ones are covered through their jobs. But in an age of gig employment, more are falling off the “26 insurance cliff” and landing hard. For a project produced…
Replicating Readmission Reduction Success in the Safety Net
Zuckerberg San Francisco General Hospital’s Lucas Zier, M.D., saw an opportunity to use the EHR for system-wide performance improvement
Pfizer Gets Another Dose of Disappointment as Sickle Cell Disease Drug Fails Pivotal Test
Pfizer’s inclacumab did not beat a placebo in a Phase 3 test in sickle cell disease. The trial failure comes nearly a year after Pfizer voluntarily withdrew Oxbryta from the market after tests showed higher rates of complications and deaths for that sickle cell disease drug. The post Pfizer Gets Another Dose of Disappointment as…
KFF/ESPN Survey of 1988 NFL Players Finds the Vast Majority Say Pro Football Left Them With a Range of Serious Health Problems, but Most Would Play Again and Encourage Their Kids To Play
KFF and ESPN today jointly released a first-of-its-kind, in-depth polling and reporting project that sheds new light on the health issues and other challenges facing NFL players after they leave the game.
KFF/ESPN Survey of 1988 NFL Players Finds the Vast Majority Say Pro Football Left Them With a Range of Serious Health Problems, but Most Would Play Again and Encourage Their Kids To Play
KFF and ESPN today jointly released a first-of-its-kind, in-depth polling and reporting project that sheds new light on the health issues and other challenges facing NFL players after they leave the game. The KFF/ESPN Survey of 1988 NFL Players draws on a novel survey of 546 respondents who were among the 1,532 players from the…More
A Look at the New Executive Order and the Intersection of Homelessness and Mental Illness
This brief describes the new executive order, examines the intersection of homelessness and mental illness, reviews the history of the deinstitutionalization movement, and discusses specialized treatment services for people with SMI.